Page last updated: 2024-08-18

pyrazolanthrone and s 1033

pyrazolanthrone has been researched along with s 1033 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Caballero, E; García-Cárceles, J; Gil, C; Martínez, A1
Chang, SP; Chen, YC; Huang, HM; Lee, WR; Shen, SC1
Dong, Q; Ge, J; Huang, Q; Tian, S; Zhao, L; Zhu, H1

Reviews

1 review(s) available for pyrazolanthrone and s 1033

ArticleYear
Kinase Inhibitors as Underexplored Antiviral Agents.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Animals; Antiviral Agents; Drug Repositioning; Humans; Protein Kinase Inhibitors; Virus Diseases; Viruses

2022

Other Studies

2 other study(ies) available for pyrazolanthrone and s 1033

ArticleYear
Nilotinib induction of melanogenesis via reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells.
    Experimental dermatology, 2018, Volume: 27, Issue:12

    Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Enzyme Activation; Imatinib Mesylate; MAP Kinase Kinase 4; Melanins; Melanocytes; Melanoma, Experimental; Mice; Mitochondria; Protein-Tyrosine Kinases; Pyrimidines; Reactive Oxygen Species

2018
Integrative identification of unexpected kinase-inhibitor interactions in the MAPK-mediated proliferation and differentiation of Mc3T3-E1 osteoblasts.
    General physiology and biophysics, 2019, Volume: 38, Issue:1

    Topics: Aniline Compounds; Animals; Anthracenes; Cell Differentiation; Cell Line; Cell Proliferation; Dasatinib; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Nitriles; Osteoblasts; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines

2019